The Tri-Valley's flourishing life sciences companies will be the focus of the second annual Tri-Valley Life Sciences Summit on Oct. 2 at Veeva Systems, 4280 Hacienda Drive in Pleasanton, organizers told the Weekly.
The session will feature a report by Lauren Moone of Mirador Capital Partners that details the venture capital investment of $590 million into Tri-Valley-based life science companies in 2018. That includes the valley's first unicorn, 10X Genomics of Pleasanton, that is valued at $1.28 billion. The company was formed in 2012.
"The Tri-Valley has developed a reputation as an ideal location to start and grow life sciences businesses," Lauren Moone, executive vice president of Mirador Capital Partners, commented in a press release. "Companies here thrive financially and attract top talent as employees seek a higher quality of life away from Silicon Valley. It's a win-win."
The event is designed for both companies and professionals to learn more about the life sciences ecosystem in the Tri-Valley.
Hosted by Veeva Systems and sponsored by Tri-Valley Ventures and Mirador Capital Partners, the summit will feature an analysis of the life sciences in the Tri-Valley investment landscape, panels covering how to build and scale life sciences companies, and an inside look at why the Tri-Valley is an ideal location for new and existing businesses.
"This is an area where companies come to build their business for the long term -- not just to get off the starting block. This summit shows how that evolving Life Science ecosystem, fed by entrepreneurs making the decision to locate here is shaping the region's future," said Greg Hitchan, co-founder and managing partner of Tri-Valley Ventures. "Investors and the rest of the Bay Area can benefit from understanding and seeing the Tri-Valley's momentum."
There is no charge to attend the event that runs from 6-9 p.m.